298474
Institutional and structural barriers to HIV testing: Elements for a theoretical framework
Methods: A qualitative, grounded theory study was conducted using secondary data from a 2011 HIV test site evaluation data in a Midwestern, moderate HIV incidence state.
Results: Expressions of structural and institutional stigma were found with over half of the testing sites and at three stages of the HIV testing visit. Examples of structural stigma included social geography, organization and staff behavior at first encounter and reception, and staff behavior when experiencing the actual HIV test. Institutional stigma was socially expressed through staff behavior at entry/reception and when experiencing the HIV test.
Conclusions: The emerging elements demonstrate the potential compounding of stigma experiences with deleterious effect. Study findings may inform future development of a theoretical framework. In practice, findings can guide organizations seeking to reduce HIV testing barriers, as they provide a window into how test seekers experience HIV test sites at first encounter, entry/reception and at testing stages; and can identify how stigma might be intensified by structural and institutional expressions.
Learning Areas:
Public health or related researchSocial and behavioral sciences
Learning Objectives:
Describe institutional and structural elements of stigma identified in HIV testing services
Identify the compounding impacts of stigma in the testing visit itself
Discuss opportunities for system and services improvements
Keyword(s): HIV/AIDS, Health Care Access
Qualified on the content I am responsible for because: Dr. Meyerson has led several studies in HIV prevention and testing with focus on community access and participatory research. She is Co-Director of the Rural Center for AIDS/STD Prevention at Indiana University School of Public Health-Blooomington and was formerly president of Policy Resource Group, LLC a firm specializing in HIV and STD policy and systems research.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.